A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury (Q44071763)

29 November 2017

A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury (English)

1 reference

29 November 2017

Edgar Ben-Josef

1

1 reference

29 November 2017

Sue Han

2

1 reference

29 November 2017

Martin Tobi

3

1 reference

29 November 2017

Leslie M Shaw

4

1 reference

29 November 2017

Heather S Bonner

5

1 reference

29 November 2017

Barbara J Vargas

6

1 reference

29 November 2017

Sharon Prokop

7

1 reference

29 November 2017

Beth Stamos

8

1 reference

29 November 2017

Laura Kelly

9

1 reference

29 November 2017

Sandra Biggar

10

1 reference

29 November 2017

Irving Kaplan

11

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

International Journal of Radiation Oncology Biology Physics

29 November 2017

1 reference

29 November 2017

53

1 reference

29 November 2017

1160-1164

1 reference

29 November 2017

5

1 reference

Defining a dose-response relationship with radiotherapy for prostate cancer: is more really better?

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Topical application of WR-2721 achieves high concentrations in the rectal wall

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Modeling the effects of inhomogeneous dose distributions in normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Analysis of the dose-surface histogram and dose-wall histogram for the rectum and bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

A new three-dimensional dose distribution reduction scheme for tubular organs

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Use of radiation with or without WR-2721 in advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. A phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902883-3

7 January 2021

10.1016/S0360-3016(02)02883-3

Identifiers

DOI

1 reference

release_hrmuu2asj5bu3dca5qoq63mmyq

29 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hrmuu2asj5bu3dca5qoq63mmyq

24 November 2022

mapped directly with Wikidata item

1 reference